Literature DB >> 16167020

BSA-based dosing and alternative approaches.

Alex Sparreboom.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16167020

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

1.  Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6.

Authors:  Rajesh R Kaldate; Abebe Haregewoin; Charles E Grier; Stephanie A Hamilton; Howard L McLeod
Journal:  Oncologist       Date:  2012-03-01

2.  The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525.

Authors:  H Ian Robins; Jens Eickhoff; Mark R Gilbert; Terri S Armstrong; Wenyin Shi; John F De Groot; Christopher J Schultz; Grant K Hunter; Egils Valeinis; Mack Roach; Emad F Youssef; Luis Souhami; Steve P Howard; Frank S Lieberman; James G Herman; Peixin Zhang; Minesh P Mehta
Journal:  Neurooncol Pract       Date:  2019-04-06

3.  Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents.

Authors:  E Chatelut; M L White-Koning; R Hj Mathijssen; F Puisset; S D Baker; A Sparreboom
Journal:  Br J Cancer       Date:  2012-08-28       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.